肝内胆管癌患者术后预后研究

doi:10.3969/j.issn.1672-5069.2018.04.045

Abstract

QinShengli, Dong Yan, Sun Yi. Prognosis of patients with intrahepatic cholangiocarcinoma[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 643-644.

[1] Richard T,Schlinkert,David M,et al.Intrahepatic cholangiocarcinoma:clinical aspects,pathology and treatment.HPB Surg,1992,5(2): 95-102.
[2] 董娜娜,段晓峰,张倜,等.103例肝内胆管癌临床病理及诊治分析.中国肿瘤临床,2012,39(6):340-342,347.
[3] 毕超,王黎明,安松林,等.123例肝内胆管癌患者手术切除后的生存分析.中华肿瘤杂志,2016,38(6):466-471.
[4] 郝文胜,张东成,桂东,等.替吉奥联合奥沙利铂一线治疗晚期肝内胆管癌患者疗效和安全性评价.实用肝脏病杂志,2015,18(4):415-417.
[5] 刘振国,强永乾.螺旋CT 和MRI 对肝内周围型胆管癌诊断价值分析.实用肝脏病杂志,2016,19(5):591-594.
[6] Sulpice L,Rayar M,Boucher E, et al.Intrahepatic cholangiocarcinoma: impact of genetic hemochromatosis on outcome and overall survival after surgical resection.J Surg Res,2013,180(1):56-61.
[7] Timothy M.Pawlik.Intrahepatic cholangiocarcinoma:from diagnosis to treatment.Hepatobiliary Surg Nutr,2017,6(1):1.
[8] Vallin M, Sturm N, Lamblin G, et al.Unrecognized intrahepatic cholangiocarcinoma: an analysis of 993 adult cirrhotic liver explants.Clin Transplant,2013,27(3):403-409.
[9] Yuan L,Luo XW,Lu XY,et al.Comparison of clinicopathological characteristics between cirrhotic and non-cirrhotic patients withintrahepatic cholangiocarcinoma:a large-scale retrospective study.Mol Clin Oncol,2017,7(4): 615-622.
[10] 周少君,黄志勇.肝内胆管癌根治性切除术后肿瘤复发转移的预后因素分析.中国普通外科杂志,2014,23(8):1024-1029.
[11] Giulia M,Isabella P,Maria G,et al.Serum markers of intrahepatic cholangiocarcinoma.Dis Markers,2013,34(4):219-228.
[12] 赵琳,曹梦晗,王民宪,等.血清肿瘤标记物联合检测鉴别肝内胆管癌和肝细胞癌.中国中西医结合外科杂志,2014,20(2):123-126.

[1]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[2]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[3]	Zhuang Taiping, Yin Yangyan, Xie Manfang, et al. Comparison of clinical features of infants with human cytomegalovirus infection and of infantile hepatitis syndrome [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 514-517.
[4]	Peng Silu, Liu Bing, Sun Hong, et al. Prognosis of patients with hepatitis B-induced acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 545-548.
[5]	Zhang Tingting, Wang Xuan. Clinical implications of oral glucose tolerance test in cirrhotic patients with hepatogenous diabetes [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 449-452.
[6]	Gao Pengbin, Zhao Xiaoyan, Qin Hao, Wu Fengying, Zhang Haizhen, Wang Lin, Jia Huina, Li Shujuan. Risk factors for poor prognosis of patients with hepatitis E-induced liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 220-223.
[7]	Wang Huming, Fan Dongsheng, Xu Jie, Liu Xianfegn, Zhou Ning, Li Min, Bao Nana. Cancerous miRNA-30c levels affecting the survival of patients with hepatocellular carcinoma after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 248-251.
[8]	Zhang Xiaozhou, Shuai Ling, Wang Qingda, Yang Nan. Changes of serum miR-335 levels in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 268-271.
[9]	Ma Deyuan, Ma Yuanfeng, Zhang Dianlong, et al.. Prognostic efficacy of serum keratin 18 in patients with hepatitis B virus-related acute on chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 77-80.
[10]	Ma Lyuxiang, Zhang Xuesong.. Efficacy and prognosis of ultrasound-guided percutaneous radiofrequency ablation in treatment of patients with small hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 125-128.
[11]	Yu Xutong, Jiang Xiuhua, Qi Tingting, et al.. Verification of bleeding criteria in patients with acute-on-chronic liver failure: A prospective study [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 885-889.
[12]	Hongjie, Zhou Dongfang.. Efficacy of entecavir and Chinese herbal medicine combination therapy in patients with hepatitis B-induced liver cirrhosis An [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 903-906.
[13]	Baoyan, Wang Yun, Xiang Xiaogang, et al.. Prognosis of patients with hepatocellular carcinoma and underlying hepatitis B An [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 924-927.
[14]	Wu Xiaojing, Dan Haijun, Sun Li, et al.. Characteristics of contrast-enhanced ultrasound in diagnosis of patients with intrahepatic cholangiocarcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 803-804.
[15]	Huang Jianwen, Yang Youchao, Xu Changqing. et al. Prognosis of patients with primary liver cancer after radical tumor resection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 521-524.

Prognosis of patients with intrahepatic cholangiocarcinoma

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments